Literature DB >> 15045626

Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing.

Abdellah El Maghraoui1, Souad Chaouir, Ahmed Abid, Ahmed Bezza, Fatima Tabache, Lahsen Achemlal, Ali Abouzahir, Driss Ghafir, Victor Ohayon, Moulay Idriss Archane.   

Abstract

The aim of this study was to identify the spectrum of abnormalities revealed on high-resolution computerized tomography (HRCT) in patients with ankylosing spondylitis (AS), to compare findings with those of plain radiography and pulmonary function testing (PFT), and to look for correlations between lung involvement and AS severity. We prospectively studied 55 consecutive patients with a diagnosis of AS according to the modified New York criteria who attended our department over a period of 2 years. All patients had a detailed rheumatological examination and underwent plain chest radiography, chest HRCT and PFT. HRCT revealed abnormalities in 29 patients (52.7%), whereas plain chest radiography was abnormal in only 2. Abnormalities consisted of interstitial lung disease (ILD) ( n=4), apical fibrosis ( n=5), emphysema ( n=5), bronchiectasis ( n=4), ground glass attenuation ( n=2), and non-specific interstitial abnormalities ( n=26). Only apical fibrosis and bronchiectasis were statistically more frequent with increasing disease duration (significant trend chi(2)test, p=0.0029 and 0.028, respectively). PFT showed a restrictive process in 19 patients (34.5%). No correlation was noted between HRCT and PFT, nor with AS symptomatic and structural severity parameters. However, there was a statistically significant correlation between PFT and AS symptomatic and structural severity parameters. In conclusion,: this study confirms that the chest HRCT of patients with AS showed a great number of abnormalities undetectable by standard X-rays. The high incidence of lung abnormalities emphasizes the importance of excluding such a diagnosis in patients with AS even without respiratory symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 15045626     DOI: 10.1007/s10067-003-0845-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

Review 1.  The role of high resolution computed tomography in the diagnosis of interstitial lung disease.

Authors:  D M Hansell; I H Kerr
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

Review 2.  High resolution computed tomography of diffuse lung disease.

Authors:  G Gamsu; J S Klein
Journal:  Clin Radiol       Date:  1989-11       Impact factor: 2.350

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis--correlation with clinical findings, pulmonary function testing and plain radiography.

Authors:  I P Casserly; H M Fenlon; E Breatnach; S M Sant
Journal:  Br J Rheumatol       Date:  1997-06

5.  Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study.

Authors:  J F Maillefert; L S Aho; A El Maghraoui; M Dougados; C Roux
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

6.  Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease.

Authors:  A El Maghraoui; M Dougados; E Freneaux; S Chaussade; B Amor; M Breban
Journal:  Rheumatology (Oxford)       Date:  1999-06       Impact factor: 7.580

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12

9.  Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis.

Authors:  M Ferdoutsis; D Bouros; G Meletis; G Patsourakis; N M Siafakas
Journal:  Respiration       Date:  1995       Impact factor: 3.580

10.  Fibrocavitating pulmonary lesions in ankylosing spondylitis.

Authors:  S S Hurwitz; A A Conlan; L P Krige
Journal:  S Afr Med J       Date:  1982-01-30
View more
  19 in total

1.  Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis.

Authors:  Pieter C Goeminne; Patrick Verschueren; Hans Scheers; Lieven J Dupont
Journal:  Clin Rheumatol       Date:  2011-09-22       Impact factor: 2.980

Review 2.  [Pulmonary manifestations in rheumatic systemic diseases].

Authors:  T Schlossbauer; C Becker-Gaab; R Eibel
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

3.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

Review 4.  A patient with ankylosing spondylitis who presented with chronic necrotising aspergillosis: report on one case and review of the literature.

Authors:  Omer Nuri Pamuk; Orbay Harmandar; Birsen Tosun; Yener Yörük; Necati Cakir
Journal:  Clin Rheumatol       Date:  2004-12-23       Impact factor: 2.980

Review 5.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms].

Authors:  U Kiltz; M Rudwaleit; J Sieper; D Krause; J-F Chenot; A Stallmach; S Jaresch; U Oberschelp; E Schneider; B Swoboda; H Böhm; A Heiligenhaus; U Pleyer; W-H Böhncke; M Stemmer; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

7.  Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms.

Authors:  F Figen Ayhan-Ardic; Oznur Oken; Z Rezan Yorgancioglu; Nilgun Ustun; F Dilek Gokharman
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

8.  Pulmonary function in ankylosing spondylitis: association with clinical variables.

Authors:  A J L Brambila-Tapia; A D Rocha-Muñoz; L Gonzalez-Lopez; M Vázquez-Del-Mercado; M Salazar-Páramo; I P Dávalos-Rodríguez; L De la Cerda-Trujillo; M L Diaz-Toscano; P Hernandez-Cuervo; V Diaz-Rizo; D Sanchez-Mosco; J C Vazquez-Jimenez; E G Cardona-Muñoz; J I Gamez-Nava
Journal:  Rheumatol Int       Date:  2013-03-30       Impact factor: 2.631

9.  Lung parenchymal changes in patients with ankylosing spondylitis.

Authors:  Zehra Isik Hasiloglu; Nuri Havan; Aylin Rezvani; Mustafa Akif Sariyildiz; Halil Eren Erdemli; Ilhan Karacan
Journal:  World J Radiol       Date:  2012-05-28

10.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.